Black Hawk Acquisition Corporation BKHAU
2.19 USD -9.16 (-80.70%)
Regular-session close
2.30 +0.11 +5.02%
After hours · Nov 20, 6:19 PM ET
2.00 Day range 2.79
2.19 52-week range 19.47
- YTD
- -81.69%
- 1 year
- -81.75%
News
globenewswire.com Vesicor Therapeutics and Black Hawk Acquisition Corporation Announce Closing of Business Combination Combined company renamed Vesicor Therapeutics Holdings, Inc.; common stock expected to begin trading on Nasdaq under the ticker symbol “VESI” on November 23, 2026 Combined company renamed Vesicor…
defenseworld.net Black Hawk Acquisition Co. (NASDAQ:BKHAU) Stock Short Interest Report for October Black Hawk Acquisition Co. (NASDAQ: BKHAU - Get Free Report) saw a large growth in short interest in October. As of October 15th, there was short interest totaling 9,247 shares, a growth of…
globenewswire.com Black Hawk Acquisition Corporation Announces Redemption Results in Connection With Its Business Combination With Vesicor Therapeutics Inc. BLACKHAWK, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Black Hawk Acquisition Corporation (NASDAQ: “BKHAU,” “BKHA,” “BKHAR”) “Black Hawk” or the “Company”) today announced that, in connection with its…
globenewswire.com Vesicor Therapeutics Appoints Michael Tolentino, M.D., as Chief Executive Officer BLACKHAWK, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- Vesicor Therapeutics, Inc., a San Gabriel, California-based early development stage biotechnology corporation focused on the development of…
globenewswire.com Black Hawk Acquisition Corporation Amends Its Definitive Proxy Statement DANVILLE, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- Black Hawk Acquisition Corporation (NASDAQ: BKHAU, the “Company”) announced today that it filed a supplement to its definitive proxy statement,…
globenewswire.com Black Hawk Acquisition Corporation Amends Its Definitive Proxy Statement DANVILLE, Calif., June 20, 2025 (GLOBE NEWSWIRE) -- Black Hawk Acquisition Corporation (NASDAQ: BKHAU, the “Company”) announced today that it filed a supplement to its definitive proxy statement,…
globenewswire.com Vesicor Therapeutics, Inc. and Black Hawk Acquisition Corporation Enter into a Business Combination Agreement to Create a Biotechnology Company Advancing p53-based Cancer Therapeutics Delivered Via Microvesicles DANVILLE, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Black Hawk Acquisition Corp. (Nasdaq: BKHAU, BKHA, BKHAR), a special purpose acquisition company, (“Black Hawk”) announced the signing of a…
globenewswire.com CORRECTION: Black Hawk Acquisition Corporation Welcomes Mr. Jonathan Ginsberg to Board DANVILLE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Black Hawk Acquisitions Corporation (NASDAQ: BKHAU), please note that the second…
globenewswire.com Black Hawk Acquisition Corporation Welcomes Mr. Jonathan Ginsberg to Board DANVILLE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Black Hawk Acquisition Corporation (NASDAQ: BKHAU, the "Company") announced today the appointment of Mr. Jonathan Ginsberg, age 33, to serve as a…
seekingalpha.com U.S. IPO Weekly Recap: Tech IPOs Pop As End Of March Approaches U.S. IPO Weekly Recap: Tech IPOs Pop As End Of March Approaches
globenewswire.com Black Hawk Acquisition Corporation Announces Closing of $69,000,000 Initial Public Offering DANVILLE, Calif., March 22, 2024 (GLOBE NEWSWIRE) -- Black Hawk Acquisition Corporation (NASDAQ: BKHAU, the “Company”) announced today that it has closed its initial public offering of 6,900,000…
globenewswire.com Black Hawk Acquisition Corporation Announces Pricing of $69,000,000 Upsized Initial Public Offering DANVILLE, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Black Hawk Acquisition Corporation (NASDAQ: BKHAU, the "Company"), a Cayman Islands exempted company, announced today that it priced its initial…
